Therapeutic alliance is associated to treatment adherence in children with juvenile idiopathic arthritis.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 21 07 2020
accepted: 25 01 2021
pubmed: 10 2 2021
medline: 29 6 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

Therapeutic alliance (TA) is the agreement between caregiver and patient during the care process. Therapeutic adherence is a major issue for the management of Juvenile Idiopathic Arthritis (JIA) requiring child's strong ability to follow treatments. The aim of this study was to evaluate the relationship between TA and adherence in patients with JIA. Observational, cross-sectional, multicenter study. Children, with JIA, aged 8-16, were included. Children, parents and physicians completed the Helping Alliance Questionnaire (HAQ-CP) for assessing TA. Adherence was measured using the Child/Parent Adherence Report Questionnaire (CARQ & PARQ). Demographic data, disease characteristics, current treatments and social environment were collected. The univariate relationship between TA and adherence, was studied by Pearson correlation coefficient. The multivariate analysis used a multiple linear regression model. A total of 119 patients were included: 68.9% girls, mean age (SD) 12.4 (2.9) years, disease duration 73.1 (48.2) months. JIA was in remission (52%), in low activity (32%) and active (16%). TA scores were high (≥80/100) for children, parents and physicians. HAQCP was highly correlated with CARQ (r=0.31; P<0.001) PARQ (r=0.37; P<0.001). In univariate analysis, disease activity (P<0.05), place of residence (P<0.01) and family status (P<0.01) were associated with child's TA. In multivariate analysis, only the place of residence (P<0.001) and the family status (P<0.05) remained associated with TA. TA strongly influences therapeutic adherence and therefore may be important for treatment effectiveness.

Identifiants

pubmed: 33561531
pii: S1297-319X(21)00023-3
doi: 10.1016/j.jbspin.2021.105151
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105151

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

Anne Lohse (A)

Rheumatology, Nord Franche-Comté Hospital, 100, route de Moval, CS10499, 90015 Belfort, France. Electronic address: anne.lohse@hnfc.fr.

Irène Lemelle (I)

Paediatric onco-haematology, University Hospital of Nancy - Brabois Hospital, Vandoeuvre-Lès-Nancy, France.

Pascal Pillet (P)

Paediatrics, Rheumatology and Paediatric Internal Medicine, Children's Hospital, Bordeaux, France.

Agnès Duquesne (A)

Nephrology-rheumatology-paediatric dermatology-Rheumatology, Mother and Child Hospital, University Hospital of Lyon, Bron, France.

Claire Ballot (C)

Paediatric haematology, Jean-Minjoz Hospital, Besançon, France.

Tu-Anh Tran (TA)

Paediatric haematology, CHU of Nîmes, Nîmes, France.

Laetitia Sparsa (L)

Rheumatology, Emile Muller Hospital, Mulhouse, France.

Laurence Goumy (L)

Paediatrics, CHU d'Angers, Angers, France.

Héloïse Reumaux (H)

Paediatric Rheumatology, Lille University Hospital, Lille, France.

Linda Rossi (L)

Paediatric Rheumatology Service, Reference Centre for Auto-inflammatory Diseases and Amylosis, Bicêtre Hospital, Kremlin-Bicêtre, France.

Elisabeth Solau-Gervais (E)

Rheumatology, University Hospital of Poitiers, Poitiers, France.

Anais Arbault (A)

Rheumatology Department, Dijon University Hospital, Dijon, France.

Camille Alleyrat (C)

Inserm CIC-1433 Clinical Epidemiology, CHRU of Nancy, University of Lorraine, Nancy, France.

Francis Guillemin (F)

Inserm CIC-1433 Clinical Epidemiology, CHRU of Nancy, University of Lorraine, Nancy, France.

Valérie Devauchelle-Pensec (V)

Rheumatology department, Cavale Blanche Hospital and Brest University, INSERM UMR 1227, Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH